Psychedelics are the real deal. They can help people in need, change the world, and make a lot of money, all at the same time. The severity of the opioid crisis has been well documented and needs a solution: One that is able to reduce the both the strain on thousands impa...
Omri Wallach
|
January 28, 2020
|
(Click image to play video.) A renewed interest in the therapeutic power psychedelic of compounds is revealing a potent and commercially viable solution. Vancouver BC-based Universal Ibogaine Inc. (UI) ( TSX-V: IBO , Forum ) is positioned to address the opioid e...
Dave Jackson
|
October 26, 2021
|
Universal Ibogaine Inc. (UI) ( TSX-V.IBO , Forum ) is a company uniquely-positioned to address the opioid epidemic through a safe, effective, and proven plant medicine – Ibogaine – and a proven treatment protocol which has successfully treated thousands of patients. ...
Dave Jackson
|
January 21, 2022
|
It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...
Marc Davis
|
April 6, 2021
|
Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills
|
December 3, 2019
|
When Stockhouse Editorial last caught up with Toronto-based CYBIN Inc. ( N.CYBN , OTC: CYBN , Forum ) back in September 2020 , the psychedelic life sciences company was just going public…and to much fanfare. Cybin is a life sciences company that views psychedelic subst...
Dave Jackson
|
October 19, 2021
|
When Stockhouse Editorial last caught up with Cybin Inc. ( NEO.CYBN , NYSE: CYBIN , Forum ) back in October, our audience learned about a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discover...
Dave Jackson
|
January 31, 2022
|
(Image via Blackberry Ltd.) The business of war weighs on the minds of investors and companies today. It is not just that, but the push to re-emerge from the COVID-19 pandemic to supply chain issues, business has been adapting. Take BlackBerry Limited ( TSX: BB...
Stockhouse Editorial
|
March 23, 2022
|
Non-invasive medical device maker Zynex Inc's. shares are trading 12% higher on an overall down market day after the company reported that Q3/19 orders are up 95% over the same period in 2018. This morning medical technology company specializing in manufacturing and s...
Streetwise Reports
|
October 3, 2019
|
Central banks around the world are currently printing more money than ever before in connection with the Corona Pandemic to keep the rest of the economy afloat and maintain social peace. The short-time work allowance is equivalent to an unconditional basic income, and given...
Mario Hose
|
July 16, 2020
|